Needle-free Blood Collection Technology PIVO™ – $10 Million Investment
Velano Vascular's technologies transform care by reducing the stress and anxiety related to blood draws during hospitalization.
The PIVO is a single-use, sterile, needle-free device that is attached to a peripheral IV catheter to obtain a blood sample without patient objection.
Especially useful for patients with Difficult Venous Access (DVA), where it is difficult to find a vein, reducing pain or bruising due to repeated needle injections.
Velano Vascular
The company's needle-free device reduces pain and discomfort for patients, and enhances safety and efficiency for providers. Founded by a patient and a physician, Velano Vascular is backed by First Round Capital, Kapor Capital and White Owl Capital. The company’s collaborators include leading U.S. hospital systems and organizations innovating in patient-centered care.
General Information
- Headquarters : San Francisco, California
- Founders : Eric Stone, Pitamber Devgon
- Categories : Health Care, Medical, Medical Device
- Founded : 2012
- Contact : velanovascular.com
Funding
- Investors : Edward Ludwig, Intermountain Healthcare, Marc Benioff, Robert Parkinson
- Funding Rounds (5) - $36.2M
- May 8, 2019 Corporate Round / $10M
- Mar 7, 2017 Series B / $17M
- Feb 8, 2016 Series A / $3.5M
- Feb 5, 2015 Series A / $5M
- Nov 13, 2014 Seed Round / $700K
Source: Velano Vascular
👉• Web: http://velanovascular.com
👉• Video
0 Comments